SAN
99.3
-3.63%↓
EI
266.2
-0.67%↓
SHL.DE
49.55
-1.14%↓
ARGX
526
-3.56%↓
FRE
38.75
-2.52%↓
SAN
99.3
-3.63%↓
EI
266.2
-0.67%↓
SHL.DE
49.55
-1.14%↓
ARGX
526
-3.56%↓
FRE
38.75
-2.52%↓
SAN
99.3
-3.63%↓
EI
266.2
-0.67%↓
SHL.DE
49.55
-1.14%↓
ARGX
526
-3.56%↓
FRE
38.75
-2.52%↓
SAN
99.3
-3.63%↓
EI
266.2
-0.67%↓
SHL.DE
49.55
-1.14%↓
ARGX
526
-3.56%↓
FRE
38.75
-2.52%↓
SAN
99.3
-3.63%↓
EI
266.2
-0.67%↓
SHL.DE
49.55
-1.14%↓
ARGX
526
-3.56%↓
FRE
38.75
-2.52%↓
24 val.
Dabar
Min
125.75
Max
128.9
Pajamos | -142M 667M |
---|---|
Pardavimai | 152M 5.4B |
P/E Sektoriaus vid. | 26.27 63.778 |
Pelnas, tenkantis vienai akcijai | 2.2 |
Dividendų pajamingumas | 1.34 |
Pelno marža | 12.311 |
EBITDA | 85M 1.6B |
Rekomendacijos | Stiprus pirkimas |
---|---|
12 mėnesių prognozė | +38.91% upside |
Dividendų pajamingumas Sektoriaus vid. | 1.34% 2.39% |
---|---|
Kitas uždarbis | 2025-05-15 |
Rinkos kapitalizacija | 33B 98B |
---|---|
Ankstesnė atidarymo kaina | 126.86 |
Ankstesnė uždarymo kaina | 127.25 |
By Trading Central
Pasitikėjimas
Strong Bearish Evidence
125.7 / 130.5 Palaikymas ir pasipriešinimas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
2025-03-06 06:27; UTC
Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results
DJ
Skaityti
2025-02-11 07:03; UTC
Germany's Merck in Talks to Buy SpringWorks Therapeutics
DJ
Skaityti
2025-02-10 16:38; UTC
SpringWorks Therapeutics Shares Rise on Report it May be Acquired
DJ
Skaityti
2025-03-06 11:18; UTC
Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk
DJ
Skaityti
2025-03-06 11:14; UTC
Merck KGaA's Outlook Signals Greater Transparency -- Market Talk
DJ
Skaityti
2025-03-06 08:20; UTC
Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk
DJ
Skaityti
2025-03-06 06:00; UTC
Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Skaityti
2025-03-06 06:00; UTC
Merck KGaA 2024 Adj EPS EUR8.63
DJ
Skaityti
2025-03-06 06:00; UTC
Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B
DJ
Skaityti
2025-03-06 06:00; UTC
Merck KGaA 2024 EBIT EUR3.645B
DJ
Skaityti
2025-03-06 06:00; UTC
Merck KGaA 2024 After-Tax Profit EUR2.79B
DJ
Skaityti
2025-03-06 06:00; UTC
Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B
DJ
Skaityti
2025-03-06 06:00; UTC
Merck KGaA 2024 EBITDA EUR5.78B
DJ
Skaityti
2025-03-06 06:00; UTC
Merck KGaA 2024 Sales EUR21.16B
DJ
Skaityti
2025-03-06 06:00; UTC
Merck KGaA Keeps Dividend at EUR2.20
DJ
Skaityti
2025-03-06 06:00; UTC
Analysts Saw Merck KGaA 2024 Sales at EUR21.14B
DJ
Skaityti
2025-03-06 06:00; UTC
Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B
DJ
Skaityti
2025-02-11 16:45; UTC
Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk
DJ
Skaityti
2025-02-11 10:54; UTC
Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk
DJ
Skaityti
2025-02-11 10:52; UTC
German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk
DJ
Skaityti
2025-01-06 13:08; UTC
Merck KGaA: Transaction closed on Dec. 23, 2024
DJ
Skaityti
2025-01-06 13:07; UTC
Merck KGaA: Didn't Disclose Financial Details
DJ
Skaityti
2025-01-06 13:06; UTC
Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio
DJ
Skaityti
2025-01-06 13:04; UTC
Merck KaA Acquires HUB Organoids Holding B.V. to Expand Its Next-Generation Biology Portfolio
DJ
Skaityti
2024-12-17 13:05; UTC
Merck: Deal Expected to Close By End Dec. 2024
DJ
Skaityti
2024-12-17 13:04; UTC
Merck: Terms of Deal Undisclosed
DJ
Skaityti
2024-12-17 13:04; UTC
Merck Signs Pact to Buy HUB Organoids
DJ
Skaityti
2024-12-17 13:03; UTC
Merck: Acquisition Advances Next Gen Biology Portfolio
DJ
Skaityti
2024-12-17 13:03; UTC
Merck to Buy HUB Organoids Holding
DJ
Skaityti
2024-11-14 11:15; UTC
Merck KGaA's Sales Target Dragged by Muted China Outlook -- Market Talk
DJ
Skaityti
Kainos pokytis
By TipRanks
12 mėnesių prognozė
Vidutinis 175.86 EUR 38.91%
Aukščiausias 190 EUR
Žemiausias 160 EUR
Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Merck KGaA kainas – Dist per pastaruosius 3 mėnesius.
By TipRanks
Stiprus pirkimas
8 ratings
6
Pirkti
2
Laikyti
0
Parduoti
Remiantis 8 analitikų, pateikusių Merck KGaA akcijų reitingus – Dist per pastaruosius 3 mėnesius.
By Trading Central
Trumpalaikis periodas
Strong Bearish Evidence
All events are bearish.
Vidutinės trukmės periodas
Neutral Evidence
The bullish and bearish events are balanced.
Ilgalaikis periodas
Strong Bearish Evidence
All events are bearish.
Pardavimo ir administravimo išlaidos
Veiklos sąnaudos
Ikimokestinis pelnas
Pardavimai
Pardavimo savikaina
Bendrasis pelnas iš pardavimo
Skolų palūkanų išlaidos
EBITDA
Veiklos pelnas
$